Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announced it has reached an agreement to be acquired by Madison Dearborn Partners (MDP). MDP, a leading private equity firm based in Chicago, will acquire a majority ownership position in Alcami from existing shareholder Ares Capital Corporation. Alcami’s […]
Post Type Archives: News
Eurofins Agroscience Services forms new regulatory business unit in Spain
As part of the ongoing regulatory service strategy focusing on growth and increasing regulatory expertise, Eurofins Agroscience Services announced that Jose-Luis Juanes and Manuel Barradas recently joined Eurofins Agroscience Services as Regulatory Team Leaders (Spain). They take responsibility for developing the business and managing a team of Regulatory Experts who constitute the newly formed company […]
Johnson Matthey reports a year of significant progress
Johnson Matthey (JM) yesterday released preliminary results for the year ended 31st March 2018. The company says the results reflect a year of significant progress against its strategy, with performance in line with expectations. Robert MacLeod, Chief Executive, commented: “We had a good year. We have made significant progress in executing our strategy and […]
Cambrex invests $5 million in laboratory expansion at Karlskoga facility
Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), has announced that it is to commence a $5 million expansion of laboratory facilities at its Karlskoga, Sweden site, to augment capability and capacity for process development and scale up, handling of potent substances, crystallization studies and solid phase characterization. […]
Stockmeier expands distribution partnership with Innospec
As of today, 1st June 2018, Stockmeier Chemie will begin selling the extensive range of products supplied by Innospec Inc. for the personal care field in the sales region Germany. This will build on the existing, successful partnership in the area of Home and Industrial Care. The product range comprises surfactants, emollients, dispersing agents, conditioners, […]
Univar closes Earthoil acquisition
Univar Inc, a global chemical and ingredient distributor and provider of value-added services, announced today that its wholly owned subsidiary, Univar Ltd., has successfully completed the acquisition of Earthoil Plantations Limited. Earthoil was a subsidiary of Treatt plc, the London-listed manufacturer and supplier of innovative ingredient solutions for the flavor, fragrance, beverage, and consumer products […]
CAMP4 Therapeutics launches with platform to discover effective treatment approaches
CAMP4 Therapeutics is on a mission to modernize the way the pharma industry discovers new treatments. Operating at the intersection of biology and computation, CAMP4 is building on seminal discoveries in gene regulation circuitry made by Company founders, Dr. Richard Young (Whitehead Institute/MIT) and Dr. Leonard Zon (Boston Children’s Hospital/Harvard University). Backing its ambitious plans, […]
Givaudan launches natural beauty range RitualEssenz TCM
Traditional Chinese Medicine (TCM) is based on the founding principle of balancing energy flows by using plant extracts to treat specific health issues. Inspired by this ancestral philosophy, Givaudan Active Beauty presents RitualEssenz TCM, an inspirational health and well-being beauty range to reconnect people with nature. RitualEssenz TCM extracts have been designed by modern and […]
BASF and Evogene to develop novel insecticides together
BASF, one of the world’s leading chemical companies, and Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced recently a new collaboration focusing on the development of novel insecticides based on new binding areas (Site-of-Action or ‘SoA’) on key insecticidal target proteins. The parties also announced that […]
Bayer wins US approval for acquisition of Monsanto
Bayer won U.S. antitrust approval for its planned takeover of Monsanto on condition that it sells about $9 billion in assets, the Justice Department said on Tuesday, clearing a major hurdle for the $62.5 billion deal. The divestiture required by U.S. antitrust enforcers “aligns closely” with divestitures the European Union required, according to a source […]